University of Hertfordshire

From the same journal

By the same authors

Standard

Judicialização de medicamentos e a assistência farmacêutica no SUS. Judicialization of medicines and pharmaceutical assistance in the SUS. / Cupertino Lentulo, Alenice; Bellan, Natalia.

In: Revista acadêmica - Oswaldo Cruz, No. 2357-8173, 01.06.2012.

Research output: Contribution to specialist publicationArticle

Harvard

APA

Vancouver

Author

Bibtex

@misc{bafc1306227f41ce943ea17a4236582f,
title = "Judicializa{\cc}{\~a}o de medicamentos e a assist{\^e}ncia farmac{\^e}utica no SUS.: Judicialization of medicines and pharmaceutical assistance in the SUS.",
abstract = "A troubling issue for managers of SUS is the increase in lawsuits for the supply of drugs. The legal basis of the lawsuits for the supply of drugs is based on the 1988 Constitution in Article 196, in guaranteeing the right to health and life. The requests range from essential medicines to unregistered drugs in the country. The variation in clinical practice develops from several parameters: the formation of the prescriber, his experiences, among other factors, makes unpredictable prescriptions and creates a difficulty for the manager plan their actions, purchase medicines and to provide appropriate assistance according and their availability to the actual needs of the patient. The development and deployment of Therapeutic Guidelines and Clinical Protocols (PCDT) accounts for a security manager about their actions and about the medications that should integrate the Pharmaceutical Assistance program, and to ensure greater patient safety that will have a health care regarding the most appropriate preventive measures, diagnostic or therapeutic targeted to a specific clinical situation. In this issue, this paper has highlighted the use of the legal route to obtain free drugs that are not included in the SUS RENAME, checking how the Pharmaceutical Assistance conducts lawsuits and how you can help in decision making among managers and the judiciary, in an attempt to ensure the best alternative, based on safety and health protection of the user.",
keywords = "Judicialization, Regulatory Science, Regulatory Affairs, medicines, health public",
author = "{Cupertino Lentulo}, Alenice and Natalia Bellan",
year = "2012",
month = "6",
day = "1",
language = "Portuguese",
journal = "Revista acad{\^e}mica - Oswaldo Cruz",

}

RIS

TY - GEN

T1 - Judicialização de medicamentos e a assistência farmacêutica no SUS.

T2 - Judicialization of medicines and pharmaceutical assistance in the SUS.

AU - Cupertino Lentulo, Alenice

AU - Bellan, Natalia

PY - 2012/6/1

Y1 - 2012/6/1

N2 - A troubling issue for managers of SUS is the increase in lawsuits for the supply of drugs. The legal basis of the lawsuits for the supply of drugs is based on the 1988 Constitution in Article 196, in guaranteeing the right to health and life. The requests range from essential medicines to unregistered drugs in the country. The variation in clinical practice develops from several parameters: the formation of the prescriber, his experiences, among other factors, makes unpredictable prescriptions and creates a difficulty for the manager plan their actions, purchase medicines and to provide appropriate assistance according and their availability to the actual needs of the patient. The development and deployment of Therapeutic Guidelines and Clinical Protocols (PCDT) accounts for a security manager about their actions and about the medications that should integrate the Pharmaceutical Assistance program, and to ensure greater patient safety that will have a health care regarding the most appropriate preventive measures, diagnostic or therapeutic targeted to a specific clinical situation. In this issue, this paper has highlighted the use of the legal route to obtain free drugs that are not included in the SUS RENAME, checking how the Pharmaceutical Assistance conducts lawsuits and how you can help in decision making among managers and the judiciary, in an attempt to ensure the best alternative, based on safety and health protection of the user.

AB - A troubling issue for managers of SUS is the increase in lawsuits for the supply of drugs. The legal basis of the lawsuits for the supply of drugs is based on the 1988 Constitution in Article 196, in guaranteeing the right to health and life. The requests range from essential medicines to unregistered drugs in the country. The variation in clinical practice develops from several parameters: the formation of the prescriber, his experiences, among other factors, makes unpredictable prescriptions and creates a difficulty for the manager plan their actions, purchase medicines and to provide appropriate assistance according and their availability to the actual needs of the patient. The development and deployment of Therapeutic Guidelines and Clinical Protocols (PCDT) accounts for a security manager about their actions and about the medications that should integrate the Pharmaceutical Assistance program, and to ensure greater patient safety that will have a health care regarding the most appropriate preventive measures, diagnostic or therapeutic targeted to a specific clinical situation. In this issue, this paper has highlighted the use of the legal route to obtain free drugs that are not included in the SUS RENAME, checking how the Pharmaceutical Assistance conducts lawsuits and how you can help in decision making among managers and the judiciary, in an attempt to ensure the best alternative, based on safety and health protection of the user.

KW - Judicialization

KW - Regulatory Science

KW - Regulatory Affairs

KW - medicines

KW - health public

M3 - Article

JO - Revista acadêmica - Oswaldo Cruz

JF - Revista acadêmica - Oswaldo Cruz

ER -